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Abstract
Objectives—To present the first national estimate of the sociodemographic, clinical, and 
behavioral characteristics of HIV-positive transgender men receiving medical care in the United 
States.
Methods—This analysis included pooled interview and medical record data from the 2009 to 
2014 cycles of the Medical Monitoring Project, which used a 3-stage, probability-proportional-to-
size sampling methodology.
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Results—Transgender men accounted for 0.16% of all adults and 11% of all transgender adults 
receiving HIV medical care in the United States from 2009 to 2014. Of these HIV-positive 
transgender men receiving medical care, approximately 47% lived in poverty, 69% had at least 1 
unmet ancillary service need, 23% met criteria for depression, 69% were virally suppressed at 
their last test, and 60% had sustained viral suppression over the previous 12 months.
Conclusions—Although they constitute a small proportion of all HIV-positive patients, more 
than 1 in 10 transgender HIV-positive patients were transgender men. Many experienced 
socioeconomic challenges, unmet needs for ancillary services, and suboptimal health outcomes. 
Attention to the challenges facing HIV-positive transgender men may be necessary to achieve the 
National HIV/AIDS Strategy goals of decreasing disparities and improving health outcomes 
among transgender persons.
Transgender persons (individuals whose gender identity differs from their sex assigned at 
birth) experience poorer health outcomes than do cisgender persons (people whose gender 
identity is concordant with the sex they were assigned at birth).1 Transgender persons 
disproportionately experience depression and sexually transmitted infections2,3 and, despite 
higher levels of educational attainment, have lower incomes and higher levels of poverty 
than do those in the general population.4 Because of structural and social factors, 
transgender persons face complications accessing necessary health care and social 
services1,2 and are disproportionately affected by HIV. 5–7 In the United States, HIV 
research on transgender men (assigned a female sex at birth) is eclipsed by that on 
transgender women (assigned a male sex at birth), mainly because estimates of HIV 
prevalence are higher (25%–31%) among transgender women than among transgender men 
(0%–3%).6 However, research suggests that transgender men who have sex with men are at 
increased risk for HIV acquisition,8,9 and transgender men constitute 15.4% of the newly 
diagnosed HIV cases among trans-gender persons.10 Transgender men are an understudied 
population lacking evidence-based HIV interventions to address their needs.
The National HIV/AIDS Strategy for the United States: Updated to 2020 (NHAS) calls for 
improving the health outcomes of people living with HIV and decreasing health disparities 
among transgender people.5 However, limited data exist for transgender persons, especially 
transgender men living with HIV, which impedes efforts to improve their health and well-
being. Surveillance systems designed to monitor health outcomes of the general population 
often lack adequate data about gender identity, making it difficult to distinguish between 
transgender and cisgender persons.9 This article is the first to present sociodemographic, 
clinical, and behavioral characteristics of HIV-positive transgender men drawn from a 
representative sample of adults receiving medical care in the United States.
METHODS
The Medical Monitoring Project (MMP) is an HIV surveillance system supported by the 
Centers for Disease Control and Prevention that produces annual nationally representative 
estimates of behavioral and clinical characteristics of HIV-positive adults receiving medical 
care in the United States. This analysis included pooled data from interviews and medical 
record abstractions from the 2009 to 2014 cycles, which used a 3-stage, probability-
proportional-to-size sampling methodology. MMP methods, including response rates, are 
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described in detail elsewhere.11 Persons eligible for MMP were HIV positive, were aged 18 
years or older, and received HIV medical care in sampled, participating facilities in a given 
cycle year.
Respondents were asked their sex assigned at birth and current gender identity. Trans-gender 
men (n = 45) were defined as respondents who reported their sex assigned at birth as female 
and identified as currently being transgender or male. Sexual activity was defined as any 
oral, anal, or vaginal sex from 2009 to 2013, but oral sex was excluded in 2014. All 
percentages reported were weighted to account for unequal selection probabilities and 
nonresponse.
RESULTS
The 45 transgender men accounted for 0.16% (95% confidence interval [CI] = 0.10, 0.21) of 
all adults and 11.0% (95% CI = 7.0, 14.0) of all transgender adults receiving HIV medical 
care in the United States from 2009 to 2014. Most (59%) transgender men were between 
ages 18 and 49 years, 47% were non-Hispanic Black, and 76% obtained the equivalent of a 
high school diploma or higher (Table 1). Approximately 53% had a sexual partner in the past 
12 months. Almost half (47%) reported household incomes at or below the federal poverty 
threshold, and 33% reported being uninsured or having only Ryan White program coverage 
for HIV medical care. Of the transgender men, 69% reported having at least 1 unmet 
ancillary service need (e.g., HIV case management, housing services, drug or alcohol 
counseling or treatment), and 23% met criteria for depression in the past 2 weeks, as 
measured by the 8-item Patient Health Questionnaire depression scale.
More than half (57%) of the transgender men had received their HIV diagnosis more than 10 
years ago, and 55% had ever met criteria for HIV disease stage 3 (AIDS). Most had been 
prescribed antiretroviral therapy (93%), and 88% reported currently taking antiretroviral 
therapy. Among those taking antiretroviral therapy, 83% reported being 100% dose adherent 
during the past 3 days. About 69% had an undetectable viral load at their most recent test, 
and 60% had maintained undetectable viral loads over the previous 12 months. The majority 
(66%) had at least 1 viral load test documented in their medical records in each 6-month 
period during the past 12 months, an indicator of regular HIV care use. However, only 40% 
reported receiving counseling from a health care provider about protecting themselves or 
partners from acquiring HIV or sexually transmitted infections.
DISCUSSION
Many transgender men receiving HIV medical care in the United States face socioeconomic 
challenges and suboptimal health outcomes. Most had at least a high school education, yet 
almost half were living at or below the federal poverty level. Although these transgender 
men had access to HIV medical care, many experienced poor health outcomes and unmet 
needs; for example, viral suppression was far lower than the NHAS goal of 80% for all 
diagnosed persons.5 HIV-positive transgender men in the United States who are not 
receiving medical care likely experience even poorer health outcomes and lower levels of 
viral suppression.
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NHAS aims to reduce HIV-related health disparities among groups such as transgender 
persons, and a recommended strategy to achieve health equity is to “support and strengthen 
capacity to implement innovative and culturally appropriate models to effectively deliver 
care along the continuum.”5(p9) We found evidence of poor health outcomes and unmet 
needs among HIV-positive transgender men receiving medical care who might benefit from 
these models. By addressing their needs and improving the health outcomes of transgender 
men living with HIV, we may help reduce disparities and decrease the risk of HIV 
transmission. Although more data are needed about HIV transmission among transgender 
men living with HIV, we found a need to improve delivery of care and prevention services 
because many were not sustainably virally suppressed and reported low rates of HIV and 
sexually transmitted infection prevention counseling.
These results were subject to several limitations. Our ability to examine characteristics 
among transgender men in greater detail was limited by the small sample size; however, the 
low proportion of transgender men in our sample was not unexpected considering the low 
estimated prevalence of HIV among transgender men and the relatively small size of the 
transgender population.6 Also, the sample size contributed to wide confidence intervals 
around our estimates; however, all but 1 estimate had acceptable coefficients of variation. 
Finally, because of MMP’s annual, cross-sectional design, 4 respondents reported 
participating in previous MMP cycles. We found no substantive differences in our estimates 
when excluding these cases, and because systematically excluding respondents who 
participated in a previous MMP cycle could bias our sample by underrepresenting 
transgender men receiving routine HIV care, we chose to include these cases in the analysis.
PUBLIC HEALTH IMPLICATIONS
More than 1 in 10 transgender persons receiving HIV care were transgender men. HIV-
positive transgender men receiving medical care in the United States constitute a small 
group with socioeconomic challenges, unmet needs for supportive services, and poor health 
outcomes. To decrease disparities and achieve health equity among transgender men, HIV 
care models could incorporate transgender-sensitive health care and mental health services 
and health insurance inclusive of sex reassignment procedures and physical sex–related 
care.12 Although more information is needed to understand how health professionals can 
improve the health and well-being of transgender men living with HIV in the United States, 
MMP data provide the first national estimates of important sociodemographic, clinical, and 
behavioral characteristics among this population.
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TABLE 1
Selected Characteristics of HIV-Positive Transgender Men Receiving Medical Care: US Medical Monitoring 
Project, 2009–2014
No. % (95% CI)
Age, y
 18–49 25 59 (43, 75)
 ≥ 50 20 41 (25, 57)
Race/ethnicity
 Non-Hispanic Black 22 47 (30, 64)
 Hispanic 11 27 (12, 42)
 Non-Hispanic White 12 26a (11, 42)
Gay or bisexual identity 18 40 (25, 56)
Educational attainment
 < high school 12 25 (13, 37)
 High school diploma or general equivalency diploma 14 34 (18, 49)
 > high school 19 42 (24, 59)
≤ federal household poverty threshold 21 47 (34, 60)
Health insurance or coverage for medical care or medications
 Any private insurance 10 22 (10, 35)
 Public insurance only 19 45 (31, 58)
 Uninsured or only Ryan White program coverage 14 33 (19, 47)
≥ 1 unmet need for ancillary support services 32 69 (54, 84)
Other or major depression, past 2 wk 10 23 (11, 36)
Sexually active 22 53 (39, 67)
Length of time since HIV diagnosis, y
 < 10 19 43 (28, 59)
 ≥ 10 26 57 (41, 72)
HIV disease stageb
 AIDS or nadir CD4 cell count 0–199 cells/μL 25 55 (39, 71)
 No AIDS and nadir CD4 cell count ≥ 200 cells/μL 20 45 (29, 61)
Antiretroviral therapy
 Prescribedb 42 93 (85, 100)
 Currently taking 40 88 (78, 99)
 Adherent to 100% of doses, past 3 d 31 83 (70, 95)
Viral suppression
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No. % (95% CI)
 Most recent viral load undetectable or ≤ 200 copies/mLb 32 69 (55, 83)
 All viral loads in past 12 mo undetectable or ≤ 200 copies/mLb 28 60 (45, 76)
Geometric mean CD4 cell count ≥ 500 cells/μLb 24 57 (41, 73)
Had ≥ 1 viral load test every 6 mob 30 66 (48, 83)
Receipt of HIV or STI prevention counseling by a health care professional 19 40 (23, 57)
Note. CI = confidence interval; STI = sexually transmitted infection. All percentages are weighted; time period is 12 mo prior to interview unless 
otherwise noted; all variables measured by interview self-report unless otherwise noted. The sample size was n = 45.
aCoefficient of variation > 0.30; estimate may be unstable.
b
Documented in medical record.
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